Acute pancreatitis is a reversible inflammatory process of the pancreas caused by auto digestion that generally presents with epigastric abdominal pain that may radiate to the back and is worsened by the ingestion of food. Acute pancreatitis is often mild, but severe disease can have a mortality rate of up to 30%. The most common causes are gallbladder disease, alcohol use, and hypertriglyceridemia. In addition to abdominal pain, patients may present with nausea and vomiting, which are nonspecific in most cases, so imaging and laboratory testing are important for definitive diagnosis. Lipase is the preferred laboratory test for diagnosing acute pancreatitis, as it is the most sensitive and specific marker for pancreatic cell damage. Additional laboratory testing, such as complete blood count (CBC) and lactate dehydrogenase (LDH) tests, are useful to obtain prognostic information.
Quick Answers for Clinicians
Abdominal pain, nausea, and vomiting are relatively nonspecific symptoms and may occur in a variety of situations. The differential diagnosis includes but is not limited to acute cholecystitis, appendicitis, cholangitis, intestinal obstruction, gastric volvulus, mesenteric ischemia, nephrolithiasis, pancreatic cancer, perforated ulcer, diabetic ketoacidosis, acute coronary syndrome, aortic dissection, ectopic pregnancy, and tubo-ovarian abscess. Appropriate laboratory testing and imaging are essential to differentiating these conditions.
The best test for diagnosis of acute pancreatitis is lipase. If lipase is >3x the upper limit of normal, it is highly likely that the patient has acute pancreatitis. Amylase should not be ordered. Although amylase was the original preferred test for acute pancreatitis and is still widely used, it is less sensitive and specific than lipase and provides no additional clinical information.
Imaging can contribute to the diagnosis of acute pancreatitis and enable assessment for local complications. The most commonly used modalities are ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance cholangiopancreatography (MRCP), and endoscopic retrograde cholangiopancreatography (ERCP).
Indications for Testing
Laboratory testing for acute pancreatitis is appropriate to support the diagnosis in patients with suspected acute pancreatitis and to contribute to prognosis.
Criteria for Diagnosis
According to the American College of Gastroenterology clinical practice guidelines, the definitive diagnosis of acute pancreatitis requires two of the criteria in the table below :
|Epigastric abdominal pain|
|Elevated lipase or amylasea concentration >3x upper limit of normal|
|Imaging findings of pancreatic inflammation|
aAmylase measurement is no longer the recommended method for the diagnosis of acute pancreatitis; see the Amylase section for more information.
The best test for acute pancreatitis is the serum lipase test. If the lipase concentration is >3x the upper limit of normal, a diagnosis of acute pancreatitis is highly likely. Serum lipase levels increase within 4-8 hours of acute pancreatitis onset and remain elevated for 8-14 days. Serial measurements are not necessary, as they do not provide prognostic information. The degree of elevation does not correlate with prognosis. Furthermore, lipase measurement is more sensitive and specific for pancreatic disease than amylase.
Amylase measurement is no longer recommended for the diagnosis of acute pancreatitis. Lipase offers improved sensitivity and specificity because amylase is also secreted by other organs. Serum amylase is initially elevated but returns to normal in 48-72 hours.
Several systems exist for estimating severity and assessing prognosis of acute pancreatitis, although there is no clinical agreement on which should be utilized. The most widely used systems include the Revised Atlanta Classification, Ranson Criteria Scoring, Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) II scale, Glasgow Prognostic Criteria (Imrie Scoring System), and the BALI score. The following laboratory tests are included in at least one of these systems and may contribute to prognosis.
Complete Blood Count
A metabolic panel should be considered to inform prognosis and guide treatment decisions. Panels should include sodium, potassium, blood urea nitrogen (BUN), creatinine, calcium, glucose, and bicarbonate to provide information about fluid status. Calcium, BUN, and glucose abnormalities may be relevant for prognosis. Complete metabolic panels that also include albumin, alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin may provide information about a possible relation to biliary tract disease.
C-reactive protein (CRP) concentrations >150 mg/dL within the first 48 hours after disease presentation suggest acute necrotizing pancreatitis. To minimize the risk of false-negative test results, CRP should be ordered 48 hours after illness onset.
Elevated concentrations of interleukin 6 are associated with a worse prognosis in certain clinical circumstances.
ARUP Laboratory Tests
Recommended test to establish diagnosis of acute pancreatitis
Automated Cell Count/Differential
Quantitative Ion-Selective Electrode/Quantitative Enzymatic/Quantitative Spectrophotometry
Panel includes albumin; alkaline phosphatase; AST; ALT; bilirubin, total; calcium; carbon dioxide; creatinine; chloride; glucose; potassium; protein, total; sodium; and urea nitrogen
Waller A, Long B, Koyfman A, et al. Acute pancreatitis: updates for emergency clinicians. J Emerg Med. 2018;55(6):769-779.
Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-2400.
McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods, 23rd ed. Elsevier, 2017.
Al Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol. 2008;14(5):675-684.
Mofidi R, Patil PV, Suttie SA, et al. Risk assessment in acute pancreatitis. Br J Surg. 2009;96(2):137-150.
Stirling AD, Moran NR, Kelly ME, et al. The predictive value of C-reactive protein (CRP) in acute pancreatitis - is interval change in CRP an additional indicator of severity? HPB (Oxford). 2017;19(10):874-880.